Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADORE: Doxycycline in Renal Disease
NCT02753426Phase 1Completed
- Sponsor
- University of California, San Francisco
- Start
- Apr 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of doxycycline in chronic kidney disease (CKD) and cardiorenal syndrome (CRS) (2 arms), sponsored by University of California, San Francisco. Primary endpoints: Serum markers of fibrosis at 3 months and Urinary markers of fibrosis at 3 months. Started Apr 2016; status: completed.
02
Drugs
doxycycline
03
Conditions
chronic kidney disease (CKD)cardiorenal syndrome (CRS)
Beyond the preview
Go deeper on NCT02753426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02753426.